Cabergoline is a new long-acting dopamine agonist that is very effective and However, a significant proportion of patients (up to 20%) does not tolerate the drug at . Statistical differences were calculated with nonparametrical tests, and the . 70% of the 58 patients in whom bromocriptine failed to...